Micthera

Welcome to MicThera, a pioneering biotech startup at the forefront of revolutionizing prostate cancer treatment. Committed to advancing healthcare through cutting-edge science, we specialize in the discovery and development of microbial derived therapeutics. Our groundbreaking approach harnesses the intricate dynamics of the microbiota to identify promising therapeutic candidates derived from commensal bacteria. With exclusive licensing rights to patented technologies, we are driving forward the discovery of a new class of medicines. Our team of experts is dedicated to meticulously researching, with the ultimate goal of offering novel, effective treatments for prostate cancer patients. Join us on our mission to reshape the landscape of cancer therapeutics through pioneering research, strategic partnerships, and a steadfast commitment to improving patient outcomes.